Trends in cervical cancer screening in Norway 2012–2017: a comparison study of non-immigrant and immigrant women

Author:

ENDEN MARTA RØTTINGEN1ORCID,MØEN KATHY1,IGLAND JANNICKE1,DIAZ ESPERANZA1ORCID

Affiliation:

1. Institute of Global Public Health and Primary Care, Faculty of Medicine, University of Bergen, Norway

Abstract

Aims: Immigrant women in Norway have lower cervical cancer screening participation than non-immigrant women. Our aim in this study was to assess whether the observed increase in screening participation during 2012–2017 was different between Norwegian-born women and immigrant women. Methods: Data were collected from three national registries. The study included 1,409,561 women, categorized according to country of birth and immigrant background: (i) Norway, Norwegian parents; (ii) Norway, immigrant parent(s); (iii) Europe, excluding Norway; (iv) Africa; (v) Asia, including Turkey; and (vi) other countries. Trends and differences between groups were analyzed using Poisson regression analyses with adjustments for variables other studies have found to influence screening participation. Trends were assessed by including half-years as a continuous variable in the models and reported as prevalence ratios with 95% confidence intervals. Results: Screening participation increased in all groups, but was not statistically significant among women from Africa in the adjusted model. The highest increase was among Norwegian women, with a 2.2% increase per year. Interaction tests showed significantly smaller increases in screening among women born in Europe ( p interaction < 0.0001), Africa ( p interaction < 0.0001), Asia ( p interaction < 0.0001), and countries in the “Other” category ( p interaction = 0.004). There was also a smaller increase among Norwegian-born women with one or more immigrant parent(s), but this was not significant ( p interaction = 0.178). Conclusions: The gap in screening participation and the increasing differences in trends suggest that healthcare services do not reach all women in Norway to the same extent. One should attempt to improve this while working toward further increasing screening participation for all.

Publisher

SAGE Publications

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer Registry of Norway. Cancer in Norway 2021 – cancer incidence, mortality, survival and prevalence in Norway. Oslo, https://www.kreftregisteret.no/globalassets/cancer-in-norway/2021/cin_report.pdf (2022, accessed 27 April 2023).

3. European Observatory on Health Systems and Policies. Norway: Health system summary. WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen, 2022. Available at: https://iris.who.int/bitstream/handle/10665/356963/9789289059053-eng.pdf?sequence=3

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3